Jessica Karins - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jessica Karins's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jessica Karins
Verified
FDA Reporter, Inside Health Policy
Falls Church
Beats
heavy metal, social media theater, entertainment media film,Rock music television, live music. classic rock
Showbiz and celebs
Content
By Jessica Karins Verified, Maaisha Osman Verified| Inside Health Policy Verified HHS is set to announce Tuesday (April 22) an FDA effort to ban use of petroleum-based synthetic food dyes, the agency said, a major shift on food policy from the Trump administration that’s likely to meet with opposition from industry. HHS did not share details of the policy change but said HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary will announce it Tuesday at HHS’ headquarters, and added the plan will mark “a major step forward in...
By Jessica Karins Verified| Inside Health Policy Verified Two FDA proposed guidance documents on reducing the risks of cell and tissue products have been sent to the White House budget office for review, the first FDA regulatory documents to advance to the Office of Management and Budget since the Trump administration began its regulatory freeze. It’s a possible sign the administration could be returning to more normal procedures for FDA guidance documents, as the submissions came a day before agencies’ deadline to submit plans to reduce the number...
By Jessica Karins Verified| Inside Health Policy Verified A Supreme Court case brought by diagnostic testing company Labcorp could impact patients’ ability to file class action lawsuits across the health care industry, according to the National Community Pharmacists’ Association (NCPA), which argued in an amicus brief the case could also harm small businesses’ ability to sue pharmacy benefit managers. At issue in the case Labcorp v.
Company Info
Inside Health Policy
InsideHealthPolicy is a subscription-based news service on the evolving debate over federal health-care policy reforms and spending.
Capitol Hill, Washington, D.C., United States, United States
+1 703-416-8505